Connect with us

Spread & Containment

The Station: ADA turns 30, Panasonic’s new battery tech and delivery (data) woes

The Station: ADA turns 30, Panasonic’s new battery tech and delivery (data) woes

Published

on

The Station is a weekly newsletter dedicated to all things transportation. Sign up here — just click The Station — to receive it every Saturday in your inbox.

Hello and welcome back to The Station, a newsletter dedicated to all the present and future ways people and packages move from Point A to Point B.

Before we get into all the mobility news and analysis of the week I wanted to flag an upcoming event that might be of interest to the budding entrepreneurs out there. TC Disrupt, that BIG annual event we hold each fall, is virtual this year. I can’t tell you everything yet, except we put a lot of effort and tech into making this interactive and exciting. This is not going to some boring webinar.

We’re adding a bunch of new events to Disrupt this year, including something we’re calling Pitch Deck Teardown. Top venture capitalists and entrepreneurs will evaluate and suggest fixes for Disrupt 2020 attendees’ pitch decks. Investors who signed up for the Pitch Deck Teardown, include Aileen Lee of Cowboy Ventures, Charles Hudson with Venture Forward, Niko Bonatsos of General Catalyst, Megan Quinn with Spark Capital, Cyan Banister of Long Journey Ventures, Roelof Botha from Sequoia and Susan Lyne with BBG.

Only pitch decks of registered Disrupt attendees will be selected. Here’s a complete breakdown of the event and how to register.

The Pitch Deck Teardown couldn’t come at a better time either. During our Early Stage event last month, Jake Saper with Emergence Capital talked about how to time your Series A fundraise. September just so happens to be a big month for investors to review pitch decks.

Alrighty then. Vamos.

Friendly reminder that you can reach out and email me anytime at kirsten.korosec@techcrunch.com to share thoughts, criticisms, offer up opinions or tips. You can also send a direct message to me at Twitter — @kirstenkorosec.

Micromobbin’

the station scooter1a

This summer is turning out to be a crucial period for scooter companies vying for permits in a handful of markets. Cities learned a thing or two during that first wave of electric scooters that hit the streets a couple of years ago. This time around, city leaders are placing more restrictions on e-scooters and limiting the number of companies allowed to operate in an urban area. That’s an important change, and one that raises the stakes for scooter companies.

First there was Paris, which awarded Dott, Lime and Tier permits to operate in the city. Now, Chicago has issued permits to Bird, Lime and Spin for its second pilot program. Chicago is limiting scooter use to 15 mph between 5 a.m. and 10 p.m. And there are few areas, like the Lakefront Trail, where scooters are prohibited.

Each scooter company is limited to no more than 3,333 devices, 50% of which must be deployed with an equity priority area. New to the second pilot is a requirement that all e-scooters must have locks that require riders to secure the scooter to a fixed object to end their trip.

On a side note, Lyft did not apply for the scooter permit. I asked Lyft, ‘why not?’ The company said it’s focusing on its expansion of Divvy, Chicago’s bike-sharing system. The city made Lyft the exclusive operator of Divvy last year and now starting to expand. The Divvy system will eventually include 16,500 bikes and 800 stations. Here’s what Lyft had to say:

“We have spent the better part of the last year working with communities in Chicago’s South and West Sides to prepare for new stations and ebikes. In order to prioritize our work with CDOT to expand Divvy and provide the highest possible experience for Divvy members, Lyft opted out of submitting an application that mirrored requests of this year’s scooter pilot. We are dedicated to the long-term success of micromobility in Chicago, and we look forward to future opportunities to work with the City to combine the benefits of bikes and scooters into one Divvy membership.”

In other micromobbin’ news …

Bird said Friday it is launching its shared e-scooters in Yonkers, New York as an “exclusive” operator. The word “exclusive” is one of those buzzwords that is tossed around a lot so I asked what this actually means. And Bird says it is the only company that will be issued a permit to operate in Yonkers. So there you have it. The company’s fleet of next-generation Bird Two scooters will be available to rent starting August 10.

bird-Yonkers scooters

Image Credits: Bird

Revel, the shared moped startup, has shut down operations in New York City following two deaths within days of each other. The startup’ blue mopeds had become a common sight in New York City. Revel, founded in March 2018 by Frank Reig and Paul Suhey, started with a pilot program in Brooklyn and later expanded to Queens. Revel has been on a fast-paced growth track, expanding to Austin, Miami and Washington, D.C in its first 18 months of operation. In January, the company launched in Oakland and recently announced plans to expand to San Francisco this August.

The company said in a statement that is reviewing its safety measures and does plan to return to New York.

Deal of the week

money the station

Prickly relations between China and the United States, particularly around trade, has not slowed the march of Chinese companies hoping to list on American stock exchanges. Li Auto is just the latest example, Rita Liao reported this week.

Li Auto is aiming for a growing Chinese middle class that aspires to drive cleaner, smarter and larger vehicles. Its first model, sold at a subsidized price of 328,000 yuan, or $46,800, is a six-seat electric SUV that began shipping at the end of last year.

The five-year-old Chinese electric vehicle startup raised $1.1 billion through its debut on Nasdaq. Li Auto priced its IPO north of its targeted range at $11.5 per share, giving it a fully diluted market value of $10 billion. It also raised an additional $380 million in a concurrent private placement of shares to existing investors.

Li Auto

Image credit: Li Auto

Other deals that got my attention this week …

Argo AI is now valued at $7.5 billion, a figure that was confirmed Thursday, nearly two months after VW Group finalized its $2.6 billion investment in the autonomous vehicle technology startup. You might recall that Argo came out of nowhere in 2017 with $1 billion (to be spread over several years) in back from Ford. Last year, VW announced it was going to invest in Argo as well.

Under the deal that was finalized last month, Ford and VW have equal ownership stakes, which will be roughly 40% each over time. The remaining equity sits with Argo’s co-founders as well as employees. Argo’s board is comprised of two VW seats, two Ford seats and three Argo seats. Ford said Thursday it netted $3.5 billion in the second quarter from selling some of its Argo equity to Volkswagen.

AUTO1 Group, the European digital used-car trading platform, raised 255 million euros ($300 million) in the form of convertible notes. The round  was led by Farallon Capital Management and the Baupost Group as well as existing investor Softbank Group, the NYT reported.

Cargo.one, a Berlin-based startup that runs a marketplace for booking air freight, closed an $18.6 million Series A round of funding led by Index Ventures. Other participants in the round include Next47 as well as prior backers Creandum, Lufthansa Cargo and Point Nine Capital. A number of angel investors also joined in, including Tom Stafford of DST Global and Carlos Gonzalez-Cadenas, the COO of GoCardless and former chief product officer of Skyscanner.

LINE MAN, the Thai food delivery platform that is a unit of Japanese chat app LINE Corp, raised $110 million from BRV Capital Management and merged with a local restaurant aggregator. LINE MAN is loading up on capital as it aims to compete with Singapore-based Grab, Indonesia’s Go-Jek and Foodpanda of Germany’s Delivery Hero SE, Reuters reported.

FreightWaves, the freight data and analytics company, raised $37 million in a round led by Kayne Partners Fund. Other investors include 8VC, Fontinalis Partners, Revolution Ventures, Hearst Ventures, Prologis Ventures, Story Ventures and Engage Ventures.

Theeb Rent-a-Car is looking into a potential initial public offering. The Saudi Arabian rental company hired Saudi Fransi Capital to advise on the IPO, Bloomberg reported.

Toyota is taking a 10% stake in BluE Nexus, a company that makes electric drive modules. The investment is part of a deepening collaboration between the two companies.

Xpeng, the Chinese electric vehicle startup and Tesla rival that just announced a $500 million Series C+ round, is reportedly in talks to raise around $300 million ahead of an initial public offering (IPO) in the United States. (back to my earlier point about interest among Chinese companies to list on U.S. stock exchanges)

Delivery and data (breaches)

Image credit: Getty

If you hadn’t noticed, delivery has been cast as one of the big success stories to emerge during the COVID-19 pandemic. I use the term “cast” because it’s not all sunshine, roses and rainbows for the delivery industry or its users.

The COVID-19 pandemic has led to a spike in demand for delivery services. It has also helped propel unprecedented consolidation as companies like Uber seek profitability.

There are challenges though, including an area that perhaps deserves A LOT MORE ATTENTION. I’m talking about data and privacy. Delivery companies, which includes a growing number of autonomous and teleoperated services, collect a ton of personal data from its customers. The kind of valuable data, like home addresses and credit card numbers, that are sold on the dark web.

This week, our cybersecurity editor Zack Whittaker reported on two data breaches involving delivery companies. The first was Drizly, one of the biggest online alcohol delivery services in the U.S. and Canada, raising over $68 million to date. Drizly told customers a hacker “obtained” some customer data. The hacker took customer email addresses, date-of-birth, passwords hashed using the stronger bcrypt algorithm and, in some cases, delivery addresses.

As many as 2.5 million Drizly accounts are believed to have been stolen. Here’s something to take note of, Drizy told TechCrunch that no financial information was compromised. However, a listing on a dark web marketplace from a well-known seller of stolen data claims otherwise. TechCrunch, of course, didn’t link to it. But Whittaker did take and share a screenshot.

Meanwhile, online shopping and delivery service Instacart is blaming customers who reused passwords for a recent spate of account breaches. The data breach compromised 270,000 Instacart customers. The company published a statement late on Thursday saying its investigation showed that Instacart “was not compromised or breached,” but pointed to credential stuffing, where hackers take lists of usernames and passwords stolen from other breached sites and brute-force their way into other accounts.

Customers can’t shoulder all of the responsibility. Instacart, as Whittaker notes, still does not support two-factor authentication, which — if customers had enabled — would have prevented the account hacks to begin with.

Other delivery news …

Flipkart, which is owned by Walmart, launched a hyperlocal service in suburbs of Bangalore, four years after the e-commerce group abruptly concluded its previous foray into this category.

The new service called Flipkart Quick uses the company’s supply chain infrastructure and a new location mapping technology framework to deliver within 90 minutes to customers more than 2,000 products across grocery, perishables, smartphones, electronics accessories and stationary items.

It’s electric

the station electric vehicles1

Remember the days when electric vehicle news was relegated to Tesla, the Nissan Leaf and Chevy Bolt? Times have changed and, well, stayed the same. Tesla still dominates the headlines and this week wasn’t any different. (more on them later). But now, there are dozens of other electric vehicle models coming to market. The upshot: charging infrastructure is becoming more important. (Hey, not everyone has a garage).

This week, GM and EVgo announced plans to add more than 2,700 new fast chargers. The rollout, which will take five years, will triple the size of the EVgo network. The first of these new EVgo fast charging stations will be available to customers starting early 2021.

The companies are targeting high-traffic areas like grocery stores, retail outlets, entertainment centers, areas where people typically spend 15 to 30 minutes. The stations, which will be powered by renewable energy, will feature new charging technology with 100 to 350-kilowatt capabilities, the companies said.

The charging partnership follows a numerous announcements from GM around its electric vehicle strategy. Earlier this week, GM said steel construction has started on the nearly 3-million-square-foot factory that will mass produce Ultium battery cells and packs. The Ultium battery, along with a modular propulsion system and electric vehicle platform, is the cornerstone of GM’ strategy to bring 20 electric vehicles to market by 2023.

GM recently released a video of its upcoming GMC Hummer EV and next week plans to reveal the Cadillac LYRIQ.

GM and EVgo charging

Image Credits: GM/EVgo

Other electric news this week …

BMW said it will offer the all-electric versions of X1 compact SUV and the 5 Series as part of the German automaker’s plans to have 25 electrified models in its portfolio by 2023.

Electric Brands is working on a VW Bus-inspired EV called the eBussy, via The Drive.

Fisker Inc. revealed in a presentation that was filed with the SEC that a “cornerstone agreement” with Volkswagen has been delayed, the Verge reported. Fisker wants to use Volkswagen’s modular EV platform for its upcoming electric vehicles.

Kandi Technologies Group, the Chinese electric vehicle and parts manufacturer, bringing two EVs to the United States through its subsidiary Kandi America. The two models, which are priced under $30,000 before federal incentives, will be the cheapest EVs in the United States.

Lucid Motors provided new details about its upcoming electric vehicle, the Air. In short, this luxury EV sedan is loaded up with hardware — dozens of sensors, a driver monitoring system and an Ethernet-based architecture — for an advanced driver assistance system that aims to match and even surpass its rivals.

There will be 32 sensors in all, according to Lucid, which has branded its advanced driver assistance system DreamDrive. Lidar, a sensor that gets a lot of attention, will be on the vehicle. But I was struck by the number of radar sensors on the Air. There will be five radars in all, giving the vehicle 360 degrees of radar coverage.

Panasonic revealed to TechCrunch this week that it developed new battery technology for the “2170” lithium-ion cells it produces and supplies to Tesla, a change that improves energy density by 5% and reduces costly cobalt content. The new, higher energy dense 2170 cells will be produced by Panasonic at Tesla’s factory in Sparks, Nevada. Improvements on the battery tech will continue with a 20% improvement in energy density over the next five years and a goal to be cobalt free.

Rivian’s retail strategy is starting to emerge. The company has said it will try and repurpose existing buildings for its stores, when possible. This week, the company said it is pursuing the purchase of the historic Laguna Beach South Coast Cinema. The theater’s present structure, was opened in 1935 and stood as the city’s only cinema until it closed its doors in August 2015.

Tesla’s sales in China are becoming increasingly important to its bottom line. An SEC filing this week shows that revenue in China climbed 102.9% year-over-year to $1.4 billion. That means China now makes up 23.3% of Tesla’s total revenues of $6 billion in the quarter, compared to just about 11% in the same period a year before.

Tesla also revealed in the same SEC filing that it received payroll-related benefits from the government, funds that helped reduce the impact of the coronavirus pandemic on its business, Reuters reported.

Speaking of Tesla … CEO Elon Musk took to Twitter on Tuesday night to say that the automaker would be “open to licensing software and supplying powertrains & batteries” to other automakers. Musk added that that would even include Autopilot, the advanced driver assistance software that Tesla offers to provide intelligent cruise control in a number of different driving scenarios. No word on whether any companies are biting.

ADA and mobility

Illustration of a group of people with a variety of disabilities cheering

Image Credits: iStock / Getty Images

The Americans with Disabilities Act of 1990 paved the way for decades of incremental changes to the way buildings, businesses and laws accommodate people with a wide variety of disabilities. As reporter Devin Coldewey notes, the law’s effect on tech has been profound.

There is still a lot of work to do. I’m looking at all of you autonomous vehicle engineers, designers and founders.

Here are a few stories that highlight the impact of ADA.

Start with Coldewey’s overview on ADA and tech. Then move over to Streetsblog, which digs into the role bicycles have played as mobility assistive devices. Finally, check out this story on Fable, a startup that aims to make disability-inclusive design easier by providing testing and development assistance from disabled folks on-demand.

See ya’ll next week. 

Read More

Continue Reading

Spread & Containment

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19…

Published

on

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19 vaccination was a mistake due to ethical and other concerns, a top government doctor warned Dr. Anthony Fauci after Dr. Fauci promoted mass vaccination.

Coercing or forcing people to take a vaccine can have negative consequences from a biological, sociological, psychological, economical, and ethical standpoint and is not worth the cost even if the vaccine is 100% safe,” Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases clinical studies unit at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), told Dr. Fauci in an email.

“A more prudent approach that considers these issues would be to focus our efforts on those at high risk of severe disease and death, such as the elderly and obese, and do not push vaccination on the young and healthy any further.”

Dr. Anthony Fauci, ex-director of the National Institute of Allergy and Infectious Diseases (NIAID. in Washington on Jan. 8, 2024. (Madalina Vasiliu/The Epoch Times)

Employing that strategy would help prevent loss of public trust and political capital, Dr. Memoli said.

The email was sent on July 30, 2021, after Dr. Fauci, director of the NIAID, claimed that communities would be safer if more people received one of the COVID-19 vaccines and that mass vaccination would lead to the end of the COVID-19 pandemic.

“We’re on a really good track now to really crush this outbreak, and the more people we get vaccinated, the more assuredness that we’re going to have that we’re going to be able to do that,” Dr. Fauci said on CNN the month prior.

Dr. Memoli, who has studied influenza vaccination for years, disagreed, telling Dr. Fauci that research in the field has indicated yearly shots sometimes drive the evolution of influenza.

Vaccinating people who have not been infected with COVID-19, he said, could potentially impact the evolution of the virus that causes COVID-19 in unexpected ways.

“At best what we are doing with mandated mass vaccination does nothing and the variants emerge evading immunity anyway as they would have without the vaccine,” Dr. Memoli wrote. “At worst it drives evolution of the virus in a way that is different from nature and possibly detrimental, prolonging the pandemic or causing more morbidity and mortality than it should.”

The vaccination strategy was flawed because it relied on a single antigen, introducing immunity that only lasted for a certain period of time, Dr. Memoli said. When the immunity weakened, the virus was given an opportunity to evolve.

Some other experts, including virologist Geert Vanden Bossche, have offered similar views. Others in the scientific community, such as U.S. Centers for Disease Control and Prevention scientists, say vaccination prevents virus evolution, though the agency has acknowledged it doesn’t have records supporting its position.

Other Messages

Dr. Memoli sent the email to Dr. Fauci and two other top NIAID officials, Drs. Hugh Auchincloss and Clifford Lane. The message was first reported by the Wall Street Journal, though the publication did not publish the message. The Epoch Times obtained the email and 199 other pages of Dr. Memoli’s emails through a Freedom of Information Act request. There were no indications that Dr. Fauci ever responded to Dr. Memoli.

Later in 2021, the NIAID’s parent agency, the U.S. National Institutes of Health (NIH), and all other federal government agencies began requiring COVID-19 vaccination, under direction from President Joe Biden.

In other messages, Dr. Memoli said the mandates were unethical and that he was hopeful legal cases brought against the mandates would ultimately let people “make their own healthcare decisions.”

“I am certainly doing everything in my power to influence that,” he wrote on Nov. 2, 2021, to an unknown recipient. Dr. Memoli also disclosed that both he and his wife had applied for exemptions from the mandates imposed by the NIH and his wife’s employer. While her request had been granted, his had not as of yet, Dr. Memoli said. It’s not clear if it ever was.

According to Dr. Memoli, officials had not gone over the bioethics of the mandates. He wrote to the NIH’s Department of Bioethics, pointing out that the protection from the vaccines waned over time, that the shots can cause serious health issues such as myocarditis, or heart inflammation, and that vaccinated people were just as likely to spread COVID-19 as unvaccinated people.

He cited multiple studies in his emails, including one that found a resurgence of COVID-19 cases in a California health care system despite a high rate of vaccination and another that showed transmission rates were similar among the vaccinated and unvaccinated.

Dr. Memoli said he was “particularly interested in the bioethics of a mandate when the vaccine doesn’t have the ability to stop spread of the disease, which is the purpose of the mandate.”

The message led to Dr. Memoli speaking during an NIH event in December 2021, several weeks after he went public with his concerns about mandating vaccines.

“Vaccine mandates should be rare and considered only with a strong justification,” Dr. Memoli said in the debate. He suggested that the justification was not there for COVID-19 vaccines, given their fleeting effectiveness.

Julie Ledgerwood, another NIAID official who also spoke at the event, said that the vaccines were highly effective and that the side effects that had been detected were not significant. She did acknowledge that vaccinated people needed boosters after a period of time.

The NIH, and many other government agencies, removed their mandates in 2023 with the end of the COVID-19 public health emergency.

A request for comment from Dr. Fauci was not returned. Dr. Memoli told The Epoch Times in an email he was “happy to answer any questions you have” but that he needed clearance from the NIAID’s media office. That office then refused to give clearance.

Dr. Jay Bhattacharya, a professor of health policy at Stanford University, said that Dr. Memoli showed bravery when he warned Dr. Fauci against mandates.

“Those mandates have done more to demolish public trust in public health than any single action by public health officials in my professional career, including diminishing public trust in all vaccines.” Dr. Bhattacharya, a frequent critic of the U.S. response to COVID-19, told The Epoch Times via email. “It was risky for Dr. Memoli to speak publicly since he works at the NIH, and the culture of the NIH punishes those who cross powerful scientific bureaucrats like Dr. Fauci or his former boss, Dr. Francis Collins.”

Tyler Durden Mon, 03/11/2024 - 17:40

Read More

Continue Reading

Government

Trump “Clearly Hasn’t Learned From His COVID-Era Mistakes”, RFK Jr. Says

Trump "Clearly Hasn’t Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President…

Published

on

Trump "Clearly Hasn't Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President Joe Biden claimed that COVID vaccines are now helping cancer patients during his State of the Union address on March 7, but it was a response on Truth Social from former President Donald Trump that drew the ire of independent presidential candidate Robert F. Kennedy Jr.

Robert F. Kennedy Jr. holds a voter rally in Grand Rapids, Mich., on Feb. 10, 2024. (Mitch Ranger for The Epoch Times)

During the address, President Biden said: “The pandemic no longer controls our lives. The vaccines that saved us from COVID are now being used to help beat cancer, turning setback into comeback. That’s what America does.”

President Trump wrote: “The Pandemic no longer controls our lives. The VACCINES that saved us from COVID are now being used to help beat cancer—turning setback into comeback. YOU’RE WELCOME JOE. NINE-MONTH APPROVAL TIME VS. 12 YEARS THAT IT WOULD HAVE TAKEN YOU.”

An outspoken critic of President Trump’s COVID response, and the Operation Warp Speed program that escalated the availability of COVID vaccines, Mr. Kennedy said on X, formerly known as Twitter, that “Donald Trump clearly hasn’t learned from his COVID-era mistakes.”

“He fails to recognize how ineffective his warp speed vaccine is as the ninth shot is being recommended to seniors. Even more troubling is the documented harm being caused by the shot to so many innocent children and adults who are suffering myocarditis, pericarditis, and brain inflammation,” Mr. Kennedy remarked.

“This has been confirmed by a CDC-funded study of 99 million people. Instead of bragging about its speedy approval, we should be honestly and transparently debating the abundant evidence that this vaccine may have caused more harm than good.

“I look forward to debating both Trump and Biden on Sept. 16 in San Marcos, Texas.”

Mr. Kennedy announced in April 2023 that he would challenge President Biden for the 2024 Democratic Party presidential nomination before declaring his run as an independent last October, claiming that the Democrat National Committee was “rigging the primary.”

Since the early stages of his campaign, Mr. Kennedy has generated more support than pundits expected from conservatives, moderates, and independents resulting in speculation that he could take votes away from President Trump.

Many Republicans continue to seek a reckoning over the government-imposed pandemic lockdowns and vaccine mandates.

President Trump’s defense of Operation Warp Speed, the program he rolled out in May 2020 to spur the development and distribution of COVID-19 vaccines amid the pandemic, remains a sticking point for some of his supporters.

Vice President Mike Pence (L) and President Donald Trump deliver an update on Operation Warp Speed in the Rose Garden of the White House in Washington on Nov. 13, 2020. (Mandel Ngan/AFP via Getty Images)

Operation Warp Speed featured a partnership between the government, the military, and the private sector, with the government paying for millions of vaccine doses to be produced.

President Trump released a statement in March 2021 saying: “I hope everyone remembers when they’re getting the COVID-19 Vaccine, that if I wasn’t President, you wouldn’t be getting that beautiful ‘shot’ for 5 years, at best, and probably wouldn’t be getting it at all. I hope everyone remembers!”

President Trump said about the COVID-19 vaccine in an interview on Fox News in March 2021: “It works incredibly well. Ninety-five percent, maybe even more than that. I would recommend it, and I would recommend it to a lot of people that don’t want to get it and a lot of those people voted for me, frankly.

“But again, we have our freedoms and we have to live by that and I agree with that also. But it’s a great vaccine, it’s a safe vaccine, and it’s something that works.”

On many occasions, President Trump has said that he is not in favor of vaccine mandates.

An environmental attorney, Mr. Kennedy founded Children’s Health Defense, a nonprofit that aims to end childhood health epidemics by promoting vaccine safeguards, among other initiatives.

Last year, Mr. Kennedy told podcaster Joe Rogan that ivermectin was suppressed by the FDA so that the COVID-19 vaccines could be granted emergency use authorization.

He has criticized Big Pharma, vaccine safety, and government mandates for years.

Since launching his presidential campaign, Mr. Kennedy has made his stances on the COVID-19 vaccines, and vaccines in general, a frequent talking point.

“I would argue that the science is very clear right now that they [vaccines] caused a lot more problems than they averted,” Mr. Kennedy said on Piers Morgan Uncensored last April.

“And if you look at the countries that did not vaccinate, they had the lowest death rates, they had the lowest COVID and infection rates.”

Additional data show a “direct correlation” between excess deaths and high vaccination rates in developed countries, he said.

President Trump and Mr. Kennedy have similar views on topics like protecting the U.S.-Mexico border and ending the Russia-Ukraine war.

COVID-19 is the topic where Mr. Kennedy and President Trump seem to differ the most.

Former President Donald Trump intended to “drain the swamp” when he took office in 2017, but he was “intimidated by bureaucrats” at federal agencies and did not accomplish that objective, Mr. Kennedy said on Feb. 5.

Speaking at a voter rally in Tucson, where he collected signatures to get on the Arizona ballot, the independent presidential candidate said President Trump was “earnest” when he vowed to “drain the swamp,” but it was “business as usual” during his term.

John Bolton, who President Trump appointed as a national security adviser, is “the template for a swamp creature,” Mr. Kennedy said.

Scott Gottlieb, who President Trump named to run the FDA, “was Pfizer’s business partner” and eventually returned to Pfizer, Mr. Kennedy said.

Mr. Kennedy said that President Trump had more lobbyists running federal agencies than any president in U.S. history.

“You can’t reform them when you’ve got the swamp creatures running them, and I’m not going to do that. I’m going to do something different,” Mr. Kennedy said.

During the COVID-19 pandemic, President Trump “did not ask the questions that he should have,” he believes.

President Trump “knew that lockdowns were wrong” and then “agreed to lockdowns,” Mr. Kennedy said.

He also “knew that hydroxychloroquine worked, he said it,” Mr. Kennedy explained, adding that he was eventually “rolled over” by Dr. Anthony Fauci and his advisers.

President Donald Trump greets the crowd before he leaves at the Operation Warp Speed Vaccine Summit in Washington on Dec. 8, 2020. (Tasos Katopodis/Getty Images)

MaryJo Perry, a longtime advocate for vaccine choice and a Trump supporter, thinks votes will be at a premium come Election Day, particularly because the independent and third-party field is becoming more competitive.

Ms. Perry, president of Mississippi Parents for Vaccine Rights, believes advocates for medical freedom could determine who is ultimately president.

She believes that Mr. Kennedy is “pulling votes from Trump” because of the former president’s stance on the vaccines.

“People care about medical freedom. It’s an important issue here in Mississippi, and across the country,” Ms. Perry told The Epoch Times.

“Trump should admit he was wrong about Operation Warp Speed and that COVID vaccines have been dangerous. That would make a difference among people he has offended.”

President Trump won’t lose enough votes to Mr. Kennedy about Operation Warp Speed and COVID vaccines to have a significant impact on the election, Ohio Republican strategist Wes Farno told The Epoch Times.

President Trump won in Ohio by eight percentage points in both 2016 and 2020. The Ohio Republican Party endorsed President Trump for the nomination in 2024.

“The positives of a Trump presidency far outweigh the negatives,” Mr. Farno said. “People are more concerned about their wallet and the economy.

“They are asking themselves if they were better off during President Trump’s term compared to since President Biden took office. The answer to that question is obvious because many Americans are struggling to afford groceries, gas, mortgages, and rent payments.

“America needs President Trump.”

Multiple national polls back Mr. Farno’s view.

As of March 6, the RealClearPolitics average of polls indicates that President Trump has 41.8 percent support in a five-way race that includes President Biden (38.4 percent), Mr. Kennedy (12.7 percent), independent Cornel West (2.6 percent), and Green Party nominee Jill Stein (1.7 percent).

A Pew Research Center study conducted among 10,133 U.S. adults from Feb. 7 to Feb. 11 showed that Democrats and Democrat-leaning independents (42 percent) are more likely than Republicans and GOP-leaning independents (15 percent) to say they have received an updated COVID vaccine.

The poll also reported that just 28 percent of adults say they have received the updated COVID inoculation.

The peer-reviewed multinational study of more than 99 million vaccinated people that Mr. Kennedy referenced in his X post on March 7 was published in the Vaccine journal on Feb. 12.

It aimed to evaluate the risk of 13 adverse events of special interest (AESI) following COVID-19 vaccination. The AESIs spanned three categories—neurological, hematologic (blood), and cardiovascular.

The study reviewed data collected from more than 99 million vaccinated people from eight nations—Argentina, Australia, Canada, Denmark, Finland, France, New Zealand, and Scotland—looking at risks up to 42 days after getting the shots.

Three vaccines—Pfizer and Moderna’s mRNA vaccines as well as AstraZeneca’s viral vector jab—were examined in the study.

Researchers found higher-than-expected cases that they deemed met the threshold to be potential safety signals for multiple AESIs, including for Guillain-Barre syndrome (GBS), cerebral venous sinus thrombosis (CVST), myocarditis, and pericarditis.

A safety signal refers to information that could suggest a potential risk or harm that may be associated with a medical product.

The study identified higher incidences of neurological, cardiovascular, and blood disorder complications than what the researchers expected.

President Trump’s role in Operation Warp Speed, and his continued praise of the COVID vaccine, remains a concern for some voters, including those who still support him.

Krista Cobb is a 40-year-old mother in western Ohio. She voted for President Trump in 2020 and said she would cast her vote for him this November, but she was stunned when she saw his response to President Biden about the COVID-19 vaccine during the State of the Union address.

I love President Trump and support his policies, but at this point, he has to know they [advisers and health officials] lied about the shot,” Ms. Cobb told The Epoch Times.

“If he continues to promote it, especially after all of the hearings they’ve had about it in Congress, the side effects, and cover-ups on Capitol Hill, at what point does he become the same as the people who have lied?” Ms. Cobb added.

“I think he should distance himself from talk about Operation Warp Speed and even admit that he was wrong—that the vaccines have not had the impact he was told they would have. If he did that, people would respect him even more.”

Tyler Durden Mon, 03/11/2024 - 17:00

Read More

Continue Reading

International

The next pandemic? It’s already here for Earth’s wildlife

Bird flu is decimating species already threatened by climate change and habitat loss.

I am a conservation biologist who studies emerging infectious diseases. When people ask me what I think the next pandemic will be I often say that we are in the midst of one – it’s just afflicting a great many species more than ours.

I am referring to the highly pathogenic strain of avian influenza H5N1 (HPAI H5N1), otherwise known as bird flu, which has killed millions of birds and unknown numbers of mammals, particularly during the past three years.

This is the strain that emerged in domestic geese in China in 1997 and quickly jumped to humans in south-east Asia with a mortality rate of around 40-50%. My research group encountered the virus when it killed a mammal, an endangered Owston’s palm civet, in a captive breeding programme in Cuc Phuong National Park Vietnam in 2005.

How these animals caught bird flu was never confirmed. Their diet is mainly earthworms, so they had not been infected by eating diseased poultry like many captive tigers in the region.

This discovery prompted us to collate all confirmed reports of fatal infection with bird flu to assess just how broad a threat to wildlife this virus might pose.

This is how a newly discovered virus in Chinese poultry came to threaten so much of the world’s biodiversity.

H5N1 originated on a Chinese poultry farm in 1997. ChameleonsEye/Shutterstock

The first signs

Until December 2005, most confirmed infections had been found in a few zoos and rescue centres in Thailand and Cambodia. Our analysis in 2006 showed that nearly half (48%) of all the different groups of birds (known to taxonomists as “orders”) contained a species in which a fatal infection of bird flu had been reported. These 13 orders comprised 84% of all bird species.

We reasoned 20 years ago that the strains of H5N1 circulating were probably highly pathogenic to all bird orders. We also showed that the list of confirmed infected species included those that were globally threatened and that important habitats, such as Vietnam’s Mekong delta, lay close to reported poultry outbreaks.

Mammals known to be susceptible to bird flu during the early 2000s included primates, rodents, pigs and rabbits. Large carnivores such as Bengal tigers and clouded leopards were reported to have been killed, as well as domestic cats.

Our 2006 paper showed the ease with which this virus crossed species barriers and suggested it might one day produce a pandemic-scale threat to global biodiversity.

Unfortunately, our warnings were correct.

A roving sickness

Two decades on, bird flu is killing species from the high Arctic to mainland Antarctica.

In the past couple of years, bird flu has spread rapidly across Europe and infiltrated North and South America, killing millions of poultry and a variety of bird and mammal species. A recent paper found that 26 countries have reported at least 48 mammal species that have died from the virus since 2020, when the latest increase in reported infections started.

Not even the ocean is safe. Since 2020, 13 species of aquatic mammal have succumbed, including American sea lions, porpoises and dolphins, often dying in their thousands in South America. A wide range of scavenging and predatory mammals that live on land are now also confirmed to be susceptible, including mountain lions, lynx, brown, black and polar bears.

The UK alone has lost over 75% of its great skuas and seen a 25% decline in northern gannets. Recent declines in sandwich terns (35%) and common terns (42%) were also largely driven by the virus.

Scientists haven’t managed to completely sequence the virus in all affected species. Research and continuous surveillance could tell us how adaptable it ultimately becomes, and whether it can jump to even more species. We know it can already infect humans – one or more genetic mutations may make it more infectious.

At the crossroads

Between January 1 2003 and December 21 2023, 882 cases of human infection with the H5N1 virus were reported from 23 countries, of which 461 (52%) were fatal.

Of these fatal cases, more than half were in Vietnam, China, Cambodia and Laos. Poultry-to-human infections were first recorded in Cambodia in December 2003. Intermittent cases were reported until 2014, followed by a gap until 2023, yielding 41 deaths from 64 cases. The subtype of H5N1 virus responsible has been detected in poultry in Cambodia since 2014. In the early 2000s, the H5N1 virus circulating had a high human mortality rate, so it is worrying that we are now starting to see people dying after contact with poultry again.

It’s not just H5 subtypes of bird flu that concern humans. The H10N1 virus was originally isolated from wild birds in South Korea, but has also been reported in samples from China and Mongolia.

Recent research found that these particular virus subtypes may be able to jump to humans after they were found to be pathogenic in laboratory mice and ferrets. The first person who was confirmed to be infected with H10N5 died in China on January 27 2024, but this patient was also suffering from seasonal flu (H3N2). They had been exposed to live poultry which also tested positive for H10N5.

Species already threatened with extinction are among those which have died due to bird flu in the past three years. The first deaths from the virus in mainland Antarctica have just been confirmed in skuas, highlighting a looming threat to penguin colonies whose eggs and chicks skuas prey on. Humboldt penguins have already been killed by the virus in Chile.

A colony of king penguins.
Remote penguin colonies are already threatened by climate change. AndreAnita/Shutterstock

How can we stem this tsunami of H5N1 and other avian influenzas? Completely overhaul poultry production on a global scale. Make farms self-sufficient in rearing eggs and chicks instead of exporting them internationally. The trend towards megafarms containing over a million birds must be stopped in its tracks.

To prevent the worst outcomes for this virus, we must revisit its primary source: the incubator of intensive poultry farms.

Diana Bell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

Trending